Published in Folia Haematol Int Mag Klin Morphol Blutforsch on January 01, 1981
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med (1996) 3.42
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med (1997) 3.35
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost (2004) 2.28
SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res (1996) 2.17
Psychological aspects and coping in haemophilic patients: a case-control study. Haemophilia (2003) 1.98
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med (1999) 1.81
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med (1997) 1.75
Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol (2000) 1.67
Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med (1997) 1.57
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview. Thromb Haemost (2000) 1.51
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest (1985) 1.44
Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)-->T) and heterozygous factor V Leiden. Haemophilia (2001) 1.43
Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost (1996) 1.42
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. Ann Oncol (2001) 1.41
Use of an algorithm for administering subcutaneous heparin in the treatment of deep venous thrombosis. Ann Intern Med (1998) 1.41
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia. Acta Haematol (1988) 1.40
Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macrothrombocytopenia. Eur J Haematol (2000) 1.40
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica (1997) 1.39
Prothrombin time using thromboplastins of different origin in hemophilia BM patients. Am J Hematol (1994) 1.38
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family. Blood Coagul Fibrinolysis (2000) 1.38
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest (1986) 1.28
Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost (1999) 1.23
Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. Proc Natl Acad Sci U S A (1985) 1.23
Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol (1998) 1.18
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med (1994) 1.17
Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet (1982) 1.13
Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med (1998) 1.10
It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia. Blood Coagul Fibrinolysis (1999) 1.08
Prothrombotic activity of oral contraceptives in patients with congenital thrombophilia varies with the defect. Clin Appl Thromb Hemost (2001) 1.07
Disendocrine manifestations during non tumoral aqueductal stenosis. J Neurosurg Sci (1986) 1.06
Effects of early maternal separation of lambs and rearing with minimal and maximal human contact on meat quality. Meat Sci (2005) 1.04
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke (1995) 1.04
Intracranial aneurysms of childhood. Childs Brain (1980) 1.04
Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med (1991) 1.02
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood (2000) 1.02
Intracerebral hematoma following evacuation of chronic subdural hematomas. Report of two cases. J Neurosurg (1986) 1.02
Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. J Clin Invest (1987) 1.01
The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost (1996) 1.01
Rheological and fibrinolytic findings in multiple sclerosis. J Neurol Neurosurg Psychiatry (1981) 1.00
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood (1999) 1.00
Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia (2000) 0.99
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. J Clin Pathol (1994) 0.98
Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease. Blut (1983) 0.97
Cancer and venous thromboembolism: an overview. Haematologica (1999) 0.96
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation (1993) 0.95
Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost (2005) 0.95
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood (1998) 0.95
Concurrent spontaneous CSF otorrhea and rhinorrhea. Eur Neurol (1982) 0.94
Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia. J Intern Med (2002) 0.93
Spontaneous spinal haematomas. Acta Neurochir (Wien) (1988) 0.93
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol (2001) 0.93
Splenomegaly as the first manifestation of thyroid cancer metastases. Tumori (1997) 0.92
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. Thromb Res (1997) 0.92
Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. J Clin Oncol (1999) 0.92
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. J Clin Invest (1990) 0.91
The effect of ellagic acid on coagulation in vivo. Blood (1966) 0.91
Effect of information about animal welfare, expressed in terms of rearing conditions, on lamb acceptability. Meat Sci (2007) 0.90
Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest (1990) 0.90
B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia. Leuk Lymphoma (1996) 0.89
Aqueductal stenosis following mumps virus infection. Case report. Ital J Neurol Sci (1985) 0.89
Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. Thromb Haemost (1996) 0.89
Risk factors for cerebral glioma in adults: a case-control study in an Italian population. J Neurooncol (1994) 0.88
Effect of information about animal welfare on consumer willingness to pay for yogurt. J Dairy Sci (2008) 0.88
The utility of non-invasive tests for detection of previous proximal-vein thrombosis. Thromb Haemost (1995) 0.88
Pidotimod: a reappraisal. Int J Immunopathol Pharmacol (2009) 0.88
Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis. Thromb Haemost (1999) 0.88
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. Folia Haematol Int Mag Klin Morphol Blutforsch (1978) 0.88
High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII. Br J Haematol (1996) 0.87
High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer (1995) 0.87
Psychological aspects and coping of parents with a haemophilic child: a quantitative approach. Haemophilia (1999) 0.87
Human brain tumors and simian virus 40. J Natl Cancer Inst (1995) 0.87
Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. Cancer (1966) 0.87
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost (1999) 0.87
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) (2008) 0.87
Severe congenital factor X deficiency in 5-month-old child. Thromb Diath Haemorrh (1970) 0.87
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. Thromb Haemost (1990) 0.87
Portal vein thrombosis in a patient with severe haemophilia A and post-hepatitis liver cirrhosis. Haematologia (Budap) (1991) 0.86
Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res (1985) 0.86
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol (1998) 0.86
Cerebral vascular accidents in young patients with essential thrombocythemia: relation with other known cardiovascular risk factors. Angiology (1998) 0.86
Contact phase of blood coagulation in diabetes mellitus. Eur J Clin Invest (1982) 0.86
Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. Blood (1991) 0.85
Severe factor X deficiency in pregnancy: case report and review of the literature. Haemophilia (2004) 0.85
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood (2000) 0.85
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene. Br J Haematol (1990) 0.85
The value of ultrasound screening for proximal vein thrombosis after total hip arthroplasty--a prospective cohort study. Thromb Haemost (2001) 0.84
Multiple brain metastases from "lymphoepithelioma-like" thymic carcinoma: a combined stereotactic-radiosurgical approach. Surg Neurol (2001) 0.84
Branch retinal vein occlusion: the pathogenetic role of blood viscosity. Ann Ophthalmol (1990) 0.84
Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol (1995) 0.84
Gamma knife radiosurgery in meningiomas of the posterior fossa. Experience with 62 treated lesions. Minim Invasive Neurosurg (2001) 0.84
Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol (2002) 0.84
The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery. Eur J Clin Invest (1981) 0.84
Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med (1978) 0.83
Clotting changes in two patients with longitudinal sinus thrombosis. Haemostasis (1980) 0.83
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation. Br J Haematol (1996) 0.83
Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient. Eur J Haematol (1990) 0.83
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis. Pediatr Nephrol (1991) 0.83